Inhibiting the Ezh2 enzyme may be counterproductive for treatment of certain cancers, including the aggressive brain tumor Group 3 medulloblastoma
Pioneering physician sets first cure rate for children with acute lymphoblastic leukemia (ALL)
St. Jude recognized for having exceptional workplace culture based upon employee surveys and an in-depth questionnaire.
The new grant supports the opening of the
St. Jude gene therapy protocol for X-linked SCID at the University of California, San Francisco (UCSF) Benioff Children's Hospital San Francisco.
In his new position, Gottschalk will be responsible for management of the department’s clinical, research and educational activities.
Three genetic changes can help identify children with the high-risk leukemia AMKL likely to benefit from allogeneic stem cell transplants.
Prolonged infection in infant with leukemia led to discovery of a mutation in the stringent response pathway that helps bacteria tolerate antibiotics.